Pharmacokinetics and extrapulmonary β2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers

Thorax

Volumn 52, Issue 10, 1997, Pages 849-852

  Lipworth, B J ^a   Clark, D J ^a   Koch, P ^b   Arbeeny, C ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

Enantiomers; Nebulised; Pharmacokinetics; Racemic; Salbutamol; 2 adrenoceptors

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; POTASSIUM; SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; PHARMACODYNAMICS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RACEMIC MIXTURE; RANDOMIZED CONTROLLED TRIAL; STEREOISOMERISM; TACHYCARDIA; TREMOR;

EID: 0030736436     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.10.849     Document Type: Article

References (19)

1. Lipworth BJ. The β-agonist controversy: fact or fiction. Clin Exp Allergy 1992;22:659 64.
2. Clark DJ, Lipworth BJ. Dose-response with inhaled drugs in asthma. Clin Pharmacokinet 1997;32:58 74.
3. Soars MR, Taylor DR, Print CG, Lake DC, Li Q, Flannery. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391 6.
4. Spitzer WO, Wuissa E, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and risk of death and near death from asthma. N Engl J Med 1992; 326:501 6.
5. Cockcroft DW, McPartland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833 7.
6. Vathenen AS, Knox AJ, Higgens BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;i:554 8.
7. 2 agonists in asthma. N Engl J Med 1992;327:1204-8.
8. Cockcroft DW, O'Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995;96:44 9.
9. 2-agonist and inhaled corticosteroid on airway responsiveness in allergen and methacholinc. Am J Respir Crit Care Med 1995;152:1485 9.
10. Sanjar S, Kristersson A, Mazoni L, Morley J, Schaeublin E. Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline. J Physiol 1990;425: 43 54.
11. Andersson RGG, Johansson F, Aberg G. Effects on bronchial reactivity and histamine release of the isomers of albuterol. Am J Respir Crit Care Med 1995;151(Suppl 2): A273
12. Mazzoni L, Naef R, Chapman ID, Morley J. Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of β-selective sympathomimetics. Pulm Pharmacol 1994;7:367 76.
13. Perrin-Fayolle M. Salbutamol in the treatment of asthma. Lancet 1995;346:1101 (letter).
14. Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989;36:239 45.
15. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yarobi A, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm Res 1992;9:588 92.
16. Walle UK, Persola GR, Walle T. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol 1993;35:413 8.
17. Eaton EA, Walle UK, Wilson HM, Aberg G, Walle T. Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br J Clin Pharmacol 1996;:41:201 6.
18. Blum P, Morley J, Gunawardena KA, Aberg GA. Fxposure to S-albuterol changes responsivity of human airways to methacholinc. Am J Respir Crit Care Med 1995;151(Suppl 2):A273.
19. Borgstrom L, Nyberg L, Jonsson S, Lindberg C, Paulson J. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol 1989;27:49 56.